Clinical trial

Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder

NCT01919008

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention FK949E Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-03-26

PhasePHASE1

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

FK949EDRUG

Sponsors & collaborators

Astellas Pharma Inclead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01919008 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.